Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06679972

Impact of Intrahepatic Cholestasis of Pregnancy on Neonatal Respiratory Outcomes

Intrahepatic Cholestasis of Pregnancy and the Respiratory Challenges of Bile Acids Pneumonia in Neonates (The CHOLE-RESP Trial)

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Carol Davila University of Medicine and Pharmacy · Academic / Other
Sex
All
Age
1 Hour – 28 Days
Healthy volunteers
Accepted

Summary

Intrahepatic cholestasis of pregnancy is a liver condition in late pregnancy, causing itching and high bile acid levels that return to normal after birth. Babies born to mothers with this condition may have a higher risk of breathing issues. Researchers suspect bile acids might lead to a specific type of lung problem in newborns, but more studies are needed to confirm this.

Detailed description

Intrahepatic cholestasis of pregnancy is a hepatic complication that predominantly arises during the second or third trimester. It is characterized by serum bile acid levels above 10 micromol/L and persistent pruritus, which resolves after delivery. To date, it has been observed that respiratory distress syndrome occurs more frequently in neonates born to mothers with cholestasis of pregnancy, and a potential new entity, 'acute bile acid-induced pneumonia,' has been proposed, though statistical confirmation is lacking. Therefore, the investigators deem it imperative to conduct a study in the neonatal population to establish a definitive conclusion regarding neonatal pulmonary impairment secondary to maternal bile acid accumulation.

Conditions

Timeline

Start date
2024-10-28
Primary completion
2027-12-10
Completion
2028-03-01
First posted
2024-11-08
Last updated
2026-02-18

Locations

1 site across 1 country: Romania

Source: ClinicalTrials.gov record NCT06679972. Inclusion in this directory is not an endorsement.